Episode Details

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

This week was a busy week on Capitol Hill but on today's episode of Health Affairs This Week, Senior Editors Leslie Erdelack and Jessica Bylander look into recent pharmaceutical and drug pricing news.

In one story, Walgreens is investing more into hospital specialty pharmacies to broaden their reach. “Today, around 25 percent of hospitals in the US have an in-house specialty pharmacy—that’s up from 9 percent from just a few years,” says Erdelack.

In another story, a dust up over 340B drug pricing program is playing out between drug companies and the federal government.

Take a break from government shutdown and Capitol Hill news and listen to Health Affairs' Leslie Erdelack and Jessica Bylander give an overview on the latest on the pharmaceutical industry.

Related Links:

• 6 Drug Companies Could Face Steep Fines For Violating 340B Law (Healthcare Dive)
• Walgreens Invests Deeper in Hospital Specialty Pharmacies (Axios)
• 340B Drug Pricing Program (Health Resources & Services Administration)

Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

Subscribe to Semafor Healthcare for free.